CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
INEX nasal implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02188589
NCT02188589N/ACompleted

Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse

Spirox, Inc.·interventional·Posted Jul 11, 2014·Updated Mar 26, 2019

In Brief

A clinical study evaluating INEX nasal implant for Nasal Valve Collapse. Completed, enrolled 30 participants across 1 site.

Detailed Summary

To evaluate the safety and feasibility of the INEX Nasal Implant in subjects with moderate to severe nasal valve collapse.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 11, 2014
Enrollment StartApr 1, 2014
Primary CompletionDec 1, 2015
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 12.0 years ago

Interventions

INEX nasal implantdevice

Treatment group may receive unilateral or bilateral INEX nasal implants (maximum of 4, 2 per side)